Stemline Therapeutics, Inc. (STML) financial statements (2021 and earlier)

Company profile

Business Address 750 LEXINGTON AVENUE
NEW YORK, NY 10022
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments164605247465444
Cash and cash equivalents149510132544
Short-term investments1515147373329 
Receivables15     0
Inventory, net of allowances, customer advances and progress billings1     
Inventory1      
Prepaid expense000000 
Deferred costs  0    
Deposits current assets10  00 
Other undisclosed current assets4300010
Total current assets:185635247475645
Noncurrent Assets
Property, plant and equipment0000000
Long-term investments and receivables  142151540
Long-term investments  142151540
Other noncurrent assets0000   
Other undisclosed noncurrent assets1      
Total noncurrent assets:20152152541
TOTAL ASSETS:187636768986085
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2221209967
Accrued liabilities0121945
Employee-related liabilities6632 22
Other undisclosed accounts payable and accrued liabilities1615157   
Deferred revenue and credits 1 00
Other liabilities0000   
Other undisclosed current liabilities1    (2)(2)
Total current liabilities:23212010945
Noncurrent Liabilities
Liabilities, other than long-term debt0000111
Deferred revenue and credits  111
Other liabilities00000  
Other undisclosed noncurrent liabilities0      
Total noncurrent liabilities:0000111
Total liabilities:232120101056
Stockholders' equity
Stockholders' equity attributable to parent164424758885580
Common stock0000000
Additional paid in capital529331251194186116111
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)0(0)
Accumulated deficit(366)(289)(204)(136)(97)(60)(31)
Total stockholders' equity:164424758885580
TOTAL LIABILITIES AND EQUITY:187636768986085

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 111100
Revenue, net11100
Cost of revenue
(Cost of Goods and Services Sold)
(5)      
Gross profit:(5)111100
Operating expenses(118)(87)(69)(40)(38)(29)(24)
Other undisclosed operating income43      
Operating loss:(79)(86)(69)(39)(38)(29)(24)
Nonoperating income (expense)211100(0)
Investment income, nonoperating3111000
Debt instrument, convertible, beneficial conversion feature      (0)
Other nonoperating income (expense)(0)(0)(0)0000
Interest and debt expense(0)(0)    (1)
Loss from continuing operations before income taxes:(77)(85)(68)(38)(37)(29)(25)
Income tax benefit016302117 
Loss before gain (loss) on sale of properties:(77)(69)(64)(38)(16)(12)(25)
Other undisclosed net loss(0)(16)(3)    
Net loss attributable to parent:(77)(85)(68)(38)(16)(12)(25)
Other undisclosed net income (loss) available to common stockholders, basic    (21)(17)0
Net loss available to common stockholders, diluted:(77)(85)(68)(38)(37)(29)(24)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(77)(85)(68)(38)(16)(12)(25)
Comprehensive loss:(77)(85)(68)(38)(16)(12)(25)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)0(22)(17)0
Comprehensive loss, net of tax, attributable to parent:(77)(85)(68)(38)(37)(29)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: